K. Zaner

Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.

Guilherme Del Fiol, Donna L Berry, Barbara Halpenny, 2013, Journal of pain and symptom management.

Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer.

L. Kachnic, K. Zaner, H. Fernando, 2011, The Journal of thoracic and cardiovascular surgery.

Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.

D. Dias-Santagata, T. Lynch, H. Willers, 2008, Clinical lung cancer.

Autologous peripheral blood stem cell transplantation for lung cancer.

Y. Humblet, K. Zaner, D. Rubinstein, 1999, Bailliere's best practice & research. Clinical haematology.

Palliative radiation therapy of symptomatic recurrent bladder cancer.

M. Yoder, K. Zaner, A. Hirsch, 2007, Pain physician.

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

C. Fenoglio-Preiser, C. Blanke, J. Abbruzzese, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Health Behaviors, Readiness to Change, and Interest in Health Promotion Programs Among Smokers With Lung Cancer and Their Family Members: A Pilot Study

L. Hayman, M. Cooley, K. Finn, 2013, Cancer nursing.

Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy.

K. Zaner, M. M. Qureshi, M. Truong, 2017, American journal of otolaryngology.

The influence of limited English proficiency on outcome in patients treated with radiotherapy for head and neck cancer.

G. Grillone, L. Kachnic, K. Zaner, 2014, Patient education and counseling.

Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines.

G. Grillone, K. Zaner, M. M. Qureshi, 2016, Practical radiation oncology.

Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB‐IV nonsmall cell lung cancer

K. Zaner, N. Ready, W. Akerley, 2006, Cancer.